Verve Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Verve Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Verve Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 84.6M shares, a 36.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 84.6M +22.5M +36.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 83.8M +22M +35.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 82M +20.2M +32.8% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 63.7M +3.29M +5.45% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 62.1M +13.4M +27.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 61.9M +13.2M +27.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 61.7M +13.2M +27.2% Dec 31, 2022 10-K 2024-02-27
Q3 2022 60.4M +12.4M +25.7% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 48.7M +763K +1.59% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 48.7M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 48.5M +45.9M +1776% Dec 31, 2021 10-K 2023-03-02
Q3 2021 48.1M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 47.9M Jun 30, 2021 10-Q/A 2021-08-16
Q4 2020 2.59M Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.